 |
|
Researchers link inflammatory diseases to increased cardiovascular risk
September 02, 2009Patients suffering from two serious autoimmune disorders which cause muscular inflammation are at increased risk of developing cardiovascular disease, says a group of Montreal researchers. Dr. Christian A. Pineau and his team at the Research Institute of the McGill University Health Centre (RI-MUHC) have linked muscular inflammation to increased cardiovascular risk for the first time. Their results were published recently in The Journal of Rheumatology.
Polymyositis (PM) and dermatomyositis (DM) are most common in women and seniors, although they can affect people of any age. Both diseases are caused by a hyperactive immune system which attacks healthy tissue, almost as if the body had become allergic to itself. This causes serious inflammation of muscle tissue in the body, leading to weakness, reduced mobility and, in the case of DM, rashes. Muscles in the heart and the lungs may also be affected.
"Inflammation has recently been recognized as a risk factor - along with hypertension and cholesterol problems - for arterial diseases that can lead to events such as heart attacks," says Dr. Pineau. Nearly one in 5,000 people suffer from PM and DM, approximately 7,000 in Canada and 75,000 across North America.
"Our results indicate that the risk of heart attack is twice as high in these people as in the general population," says Dr. Sasha Bernatsky, a study co-author. "Each year, one out of every 200 people with muscle inflammation, or myositis, succumbs to a stroke and one out of 75 to a heart attack."
The researchers also noted that the immunosuppressive therapies currently used to treat PM and DM may have a preventive effect against heart attacks. "This is an extremely interesting finding for patients who are suffering from PM and DM but who may be hesitant to undergo this type of treatment," adds Dr. Pineau, noting that some patients are concerned about the possible side-effects of immunosuppressive therapies, such as reduced immunity to infection.
"Sometimes patients do not want to undergo immunosuppressive treatment, which can last for years," adds Dr. Bernatsky. "Knowing that it has additional preventive effects may help some people decide to opt for the treatment."
Cardiovascular diseases are the world's leading cause of death, and the researchers hope that their results will provide a clearer picture of the possible benefits and possibilities of immunosuppressive treatment. As a result of their encouraging findings, Dr. Pineau and his team are now turning their attention to possible benefits of immunosuppressive therapy on other health risks associated with inflammatory diseases.
McGill University Health Centre
"Our results indicate that the risk of heart attack is twice as high in these people as in the general population," says Dr. Sasha Bernatsky, a study co-author. "Each year, one out of every 200 people with muscle inflammation, or myositis, succumbs to a stroke and one out of 75 to a heart attack."
The researchers also noted that the immunosuppressive therapies currently used to treat PM and DM may have a preventive effect against heart attacks. "This is an extremely interesting finding for patients who are suffering from PM and DM but who may be hesitant to undergo this type of treatment," adds Dr. Pineau, noting that some patients are concerned about the possible side-effects of immunosuppressive therapies, such as reduced immunity to infection.
"Sometimes patients do not want to undergo immunosuppressive treatment, which can last for years," adds Dr. Bernatsky. "Knowing that it has additional preventive effects may help some people decide to opt for the treatment."
Cardiovascular diseases are the world's leading cause of death, and the researchers hope that their results will provide a clearer picture of the possible benefits and possibilities of immunosuppressive treatment. As a result of their encouraging findings, Dr. Pineau and his team are now turning their attention to possible benefits of immunosuppressive therapy on other health risks associated with inflammatory diseases.
McGill University Health Centre
Inflammatory Disease Current Events and Inflammatory Disease News RSSTeen girls diagnosed with STI more likely to seek treatment for partners after watching video
A study at Johns Hopkins Children's Center found that girls diagnosed with pelvic inflammatory disease (PID) who watched a short educational video were three times more likely to discuss their condition with their partners and to ensure partner treatment than girls diagnosed and treated without seeing the film.
Australian study sheds light on kidney repair and disease
A study by Monash University researchers has shed new light on the microscopic antennas in the kidney that are involved in the organ's repair process.
Body's immune system response to dental plaque varies by gender and race
Will neglecting to brush your teeth damage more than just your smile? Can failing to attack dental plaque increase your risk of heart damage?
Inflammatory disease treatments will improve through the use of lipidomics
According to the National Center for Chronic Disease Prevention and Health Promotion, 46 million Americans have arthritis.
Scientists uncork a potential secret of red wine's health benefits
Scientists from Scotland and Singapore have unraveled a mystery that has perplexed scientists since red wine was first discovered to have health benefits: how does resveratrol control inflammation?
New chlamydia test offers rapid, pain-free test for men
A new urine test developed with funding from the Wellcome Trust will allow doctors to diagnose Chlamydia infection in men within the hour, improving the ability to successfully treat the infection on the spot and prevent re-transmission.
Skin-like Tissue Developed from Human Embryonic Stem Cells
Dental and tissue engineering researchers at Tufts University School of Dental Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have harnessed the pluripotency of human embryonic stem cells (hESC) to generate complex, multilayer tissues that mimic human skin and the oral mucosa (the moist tissue that lines the inside of the mouth).
Novel genetic finding offers new avenue for future Crohn's disease treatment
Researchers from Case Western Reserve University School of Medicine identified a novel link between ITCH, a gene known to regulate inflammation in the body and NOD2, a gene which causes the majority of genetic Crohn's Disease diagnoses.
Women with endometriosis need special care during pregnancy to avoid risk of premature birth
The largest study to date of endometriosis in pregnant women has found that the condition is a major risk factor for premature birth.
Patients with moderate to severe periodontitis need evaluation for heart disease risk
Additional research is called for and patients with moderate to severe periodontitis should receive evaluation and possible treatment to reduce their risk of atherosclerotic cardiovascular disease (CVD).
More Inflammatory Disease Current Events and Inflammatory Disease News Articles
 |
FlameEz-Colon, 60 Capsules/Bottle by FlameEz Inflammatory bowel disease (IBD) is caused by chronic inflammation in digestive tract which leads to severe abdominal pain and diarrhea. Crohn's disease and ulcerative colitis are the most common forms of IBD. Chronic inflammation also plays a significant role in colon cancer. Inflammation promotes oxidative damage, DNA mutation, and cell transformation. Inflammatory mediators act as a tumor promoter, stimulate the proliferation of both untransformed and tumor cells. Tumor cells also amplify inflammatory responses by attracting more inflammatory cells to infiltrate the tumor. Such vicious cycle leads to tissue disruption and metastasis. The importance of inflammation in cancer progression has already led to clinical trials of anti-inflammatory cancer therapy. It is believed that... |
 |
Pocket Guide to Inflammatory Bowel Disease by Sunanda V. Kane (Editor), Marla C. Dubinsky (Editor) Patients with Inflammatory Bowel Disease (IBD) present special challenges for practitioners, whether in the office, in the clinic, or on the telephone. This easy to read, easy to use pocket guide has been written by respected clinicians to help anyone who cares for IBD patients identify key problems and make decisions about treatment. Each chapter is devoted to a particular complaint or symptom and covers conditions to consider, questions to ask, and tests to order. The guide also contains valuable information on medications, complementary and alternative therapies, dealing with special populations, and long-term concerns such as non-adherence. |
 |
Inflammatory Bowel Disease (Home Use) Inflammatory Bowl Disease, or IBD, is an umbrella term for several different gastrointestinal illnesses, by far the most prominent and serious being Crohn's Disease and Ulcerative Colitis (UC). Of the 1.2 million Americans currently estimated to have Inflammatory Bowel Disease, about half will have developed the condition between childhood and their 20's. But IBD can strike at any age; it targets both sexes equally; and, presently, there is no cure - although in life-threatening cases, removing the colon will effectively "end" Ulcerative Colitis. In this program we'll meet patients who have had IBD for some time, and young people who are just learning to deal with the limitations. We'll visit a camp in California that plays host to kids with Crohn's and Colitis for two weeks every summer.... |
 |
Inflammatory Bowel Disease: Diagnosis and Management of Crohn's Disease and Ulcerative Colitis (NCME Video 730) Also With: Network For Continuing Medical Education (Primary Contributor), Daniel H. Present (Primary Contributor) Daniel H. Present, MD, Clinical Professor of Medicine at the Mount Sinai School of Medicine, discusses the latest thinking regarding the diagnosis and management of inflammatory bowel disease (Crohn's disease and ulcerative colitis). Within the context of hypothetical patient cases, Dr. Present discusses the differential diagnosis of inflammatory bowel disease and the various treatment options for mild-to-moderate and moderate-to-severe disease, including the therapeutic role of 5-ASA drugs, immune modifiers, and other agents. The investigational use of antibody to tumor necrosis factor [alpha] [alpha] in treatment-resistant Crohn's disease is also addressed. |
 |
Digestive Advantage Daily Dietary Management of Crohn's & Colitis Caplets, 32-Count Boxes (Pack of 2) by Digestive Advantage For Daily Dietary Management of Crohn's & Colitis. Helps relieve Inflammatory Bowel Disease symptoms! Only one per day! 24-Hour relief. Feel the advantage! Feel amazing results. Helps Relieve: Cramps; Bloating; Diarrhea; Abdominal discomfort. Digestive Ad |
 |
Pocket Guide to Inflammatory Bowel Disease (Software for download) by Skyscape This easy to read, easy to use resource has been designed with the busy health care provider in mind. Patients with Crohn's disease and ulcerative colitis - collectively known as Inflammatory Bowel Disease (IBD) - present special challenges for practitioners, whether in the office, in the clinic, or on the telephone. IBD patients typically require lifetime care, and grapple with a wide range of changing intestinal symptoms and extraintestinal concerns that can be confusing for the nonspecialist who may not know what to ask or what to do next. This resource is designed to help anyone who cares for these patients, identify the problems and make decisions about treatment. |
 |
Gastric Gold Aloe Vera AMP 90 Count Bottle by Alternative Health Products Gastric Gold is helpful in reversing and correcting many digestive and gastrointestinal tract disorders and diseases. A.M.P. (Aloe Mucilaginous Polysaccharide) the main ingredient in Gastric Gold purifies the blood, cleanses the liver, restores and protects the digestive tract, while it works to stop the damaging causes of these painful conditions: The Aloe Vera plant has been recognized for many years for its remarkable health-enhancing properties. In the past it was known for external applications for the skin only. Concentrated and stabilized Aloe (AMP) the active ingredient in Gastric Gold, is now widely used to help a variety of conditions in the digestive tract. The digestive tract is designed to ensure nutrients from food are absorbed into the blood stream while dispensing with... |
 |
Why Doesn't My Doctor Know This?: Conquering Irritable Bowel Syndrome, Inflammatory Bowel Disease, Crohn's Disease and Colitis by David Dahlman (Author) You're miserable, your quality of life has changed, your medications don't help and your doctor had the nerve to tell you that diet has nothing to do with your condition. ...but you know better! You can conquer these symptoms of Irritable Bowel Syndrome, Crohn's Disease and any form of Colitis: Gas, Bloating, Indigestion, Heartburn, Reflux, GERD, Diarrhea, Constipation, Alternating Diarrhea/Constipation, Abnormal Bowel Urgency, Abnormal Bowel Frequency, Pain, Spasms, Blood, Mucous, Hemorrhoids, Hiatal Hernia. Why Doesn't My Doctor Know This? Conquering Irritable Bowel Syndrome, Inflammatory Bowel Disease, Crohn's Disease and Colitis details the only physician designed step-by-step plan combined with dietary advice and an all natural supplement program. It will end your symptoms because it... |
 |
Living with Psoriasis Directed By: ITV Also With: ITV (Producer) |
 |
Tylan Soluble Powder 100 gram by Elanco Animal Health Tylan Soluble Powder is a water soluble product contains 100gm Tylosin Tartrate/container that is labeled for chickens and turkeys to treat chronic respiratory disease. |
| © 2009 BrightSurf.com |